Corbus Pharmaceuticals Holdings, Inc. - Rasio nilai perusahaan marang dodolan CRBP

Simbol resmi perusahaan corbuspharma.com (CRBP)

The monetization of inflammatory process research creates a foundation for long-term partnerships with industry behemoths. The Enterprise Value to Sales ratio in the daily price action on the GURU.Markets chart helps identify overheating phases, where 0.00 represents the current metric value. The resilience of Corbus Pharmaceuticals (CRBP) is guaranteed by the non-cyclical nature of oncology development and a strict materials logistics protocol that completely eliminates transportation risks.

Corbus Pharmaceuticals, Inc. (CRBP): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Corbus Pharma - rincian analitis lan metrik utama (CRBP)

- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:CRBP, corbuspharma.com
Produk sing diprodhuksi Corbus Pharmaceuticals Holdings, Inc.

This indicator determines the total business value relative to its annual revenue, excluding the impact of leverage. Investors utilize the EV/Revenue ratio to identify an asset's fair price regardless of its capital structure. An increase in this metric signals that the asset is overbought, while a decrease suggests potential undervaluation. For Corbus Pharmaceuticals (CRBP), this metric reflects market expectations regarding the commercialization of the selective drug CRB-701. High values here are justified by the uniqueness of ADC technologies in oncology.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales